Publication | Closed Access

Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial

Neck Cancer PatientsRadiation TherapyMedicineOral CavityPathologyHead And Neck CancerHead And Neck Squamous Cell CarcinomaNeck OncologyOncologyRadiation OncologyEpigallocatechin-3-gallate Mouthwash ProtectsCancer ResearchRadiation-induced Mucositis